Jones Financial Companies’s TuHURA Biosciences HURA Stock Holding History

Jones Financial Companies’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	1	–	–	﹤0.01%	4956
2026 Q1	$2	Buy	+1	New	+$1	﹤0.01%	4719

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jones Financial Companies's HURA Position: Q2 2026 in Review

Jones Financial Companies held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4956.

Jones Financial Companies first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Jones Financial Companies held 1 share of TuHURA Biosciences worth $2 as of Q2 2026.
Jones Financial Companies left its TuHURA Biosciences share count unchanged in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4956 holding.
Jones Financial Companies first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.